Mariana Oviedo, Project Manager for Veristat, provides an overview of the key items that must be taken into consideration when designing and running a long-term follow-up study for a gene therapy product, sharing experiences from both a scientific and operational perspective. It is never too early to start thinking about the long-term follow up with so much on the line.
